
Krisma 2mg/0.035mg Tablet
Marketer
Amagen India Life Sciences
Salt Composition
Cyproterone (2mg) + Ethinyl Estradiol (0.035mg)
Overview Krisma 2mg/0.035mg Tablet
Cyclen 2mg/0.035mg tablets combine two hormones to manage polycystic ovary syndrome (PCOS) symptoms like excess hair growth, acne, and menstrual irregularities. It also acts as birth control; therefore, avoid other contraceptives. This medication may be taken with or without food, consistently at the same time daily for improved adherence. Dosage and treatment length vary depending on the condition, but always finish the prescribed course. Common side effects include nausea, abdominal discomfort, headaches, weight increase, and breast tenderness. Report any concerning or persistent side effects to your physician; management strategies may be available. Mid-cycle spotting or brown discharge warrants medical attention. Seek immediate medical advice for unexplained limb swelling and pain, breathlessness, chest pain, or vision changes. If menstruation doesn't begin within a week of treatment, discontinue use and consult your doctor. Inform your doctor of all other medications you're using, as interactions may reduce efficacy or alter the drug's effects. Do not use this medication during pregnancy or breastfeeding.
Uses of Krisma 2mg/0.035mg Tablet
Managing Polycystic Ovary Syndrome (PCOS)
Major Benefits of Krisma 2mg/0.035mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Krisma 2mg/0.035mg Tablets can be consumed with or without food, although consistent daily timing is recommended.
Common Side effects of Krisma 2mg/0.035mg Tablet:
- Nausea
- Stomach pain
- Headache
- Weight gain
- Breast pain
- Mood changes
How to use Krisma 2mg/0.035mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Krisma 2mg/0.035mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Krisma 2mg/0.035mg Tablet works:
Krisma 2mg/0.035mg tablets combine cyproterone acetate and ethinyl estradiol to manage polycystic ovary syndrome (PCOS) symptoms like acne, hirsutism, and menstrual irregularities. Cyproterone acetate's action involves suppressing excess androgen production within the ovaries, consequently mitigating acne and excessive hair growth. Ethinyl estradiol complements this by further lowering circulating androgens, synergistically contributing to menstrual cycle normalization characteristic of effective PCOS treatment.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Krisma 2mg/0.035mg tablets with alcohol. Seek medical advice before doing so.
PregnancyUNSAFE
Using Krisma 2mg/0.035mg tablets during pregnancy poses a substantial risk. Pregnant women should consult their physician before use, as research in both animal and human studies indicates considerable harm to the fetus.
Breast feedingCONSULT YOUR DOCTOR
Employing Krisma 2mg/0.035mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Krisma 2mg/0.035mg Tablets.
KidneyCONSULT YOUR DOCTOR
Data regarding Krisma 2mg/0.035mg Tablet use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Krisma 2mg/0.035mg Tablet to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Krisma 2mg/0.035mg Tablet :
Should you forget to take a Krisma 2mg/0.035mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Krisma 2mg/0.035mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | OBSTETRICS AND GYNECOLOGY |
